ES541620A0 - Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes - Google Patents
Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantesInfo
- Publication number
- ES541620A0 ES541620A0 ES541620A ES541620A ES541620A0 ES 541620 A0 ES541620 A0 ES 541620A0 ES 541620 A ES541620 A ES 541620A ES 541620 A ES541620 A ES 541620A ES 541620 A0 ES541620 A0 ES 541620A0
- Authority
- ES
- Spain
- Prior art keywords
- acil
- immunostimulant
- tripeptides
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/16—Eight-membered rings
- C07D313/18—Eight-membered rings not condensed with other rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/595,169 US4565653A (en) | 1984-03-30 | 1984-03-30 | Acyltripeptide immunostimulants |
Publications (2)
Publication Number | Publication Date |
---|---|
ES541620A0 true ES541620A0 (es) | 1986-04-01 |
ES8605821A1 ES8605821A1 (es) | 1986-04-01 |
Family
ID=24382038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES541620A Expired ES8605821A1 (es) | 1984-03-30 | 1985-03-27 | Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes |
Country Status (20)
Country | Link |
---|---|
US (1) | US4565653A (es) |
EP (1) | EP0157572A3 (es) |
JP (1) | JPS60224699A (es) |
KR (1) | KR870000372B1 (es) |
AU (2) | AU552919B2 (es) |
CA (1) | CA1270098A (es) |
DD (1) | DD239406A5 (es) |
DK (1) | DK142485A (es) |
EG (1) | EG17928A (es) |
ES (1) | ES8605821A1 (es) |
FI (1) | FI851271L (es) |
GR (1) | GR850783B (es) |
HU (1) | HU198086B (es) |
IL (1) | IL74758A (es) |
NO (1) | NO851278L (es) |
NZ (1) | NZ211634A (es) |
PH (1) | PH21303A (es) |
PL (1) | PL252659A1 (es) |
PT (1) | PT80181B (es) |
ZA (1) | ZA852335B (es) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1295784C (en) * | 1985-11-25 | 1992-02-11 | James Patrick Rizzi | Peptide immunostimulants |
JPH0718039B2 (ja) * | 1986-03-26 | 1995-03-01 | 株式会社豊田自動織機製作所 | 粉末付加亜鉛めっき鋼板の製造方法 |
WO1988001612A1 (en) * | 1986-08-27 | 1988-03-10 | Pfizer Inc. | Processes and intermediates for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine |
WO1988001613A1 (en) * | 1986-08-27 | 1988-03-10 | Pfizer Inc. | Crystalline n-(s-3-methylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine, and processes and intermediates therefor |
DE3700173A1 (de) * | 1987-01-05 | 1988-07-14 | Hoechst Ag | Verfahren zur herstellung von lipophilen aminosaeurederivaten sowie lipophile aminosaeurederivate |
DE3820528A1 (de) * | 1988-06-16 | 1989-12-21 | Bayer Ag | Mittel zur insekten- und milbenabwehr |
US5245079A (en) * | 1989-02-21 | 1993-09-14 | Pfizer Inc. | Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine |
US5185464A (en) * | 1989-02-21 | 1993-02-09 | Pfizer Inc. | Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
US5248820A (en) * | 1989-02-21 | 1993-09-28 | Pfizer Inc. | Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
US5136020A (en) * | 1989-02-21 | 1992-08-04 | Pfizer Inc. | Crystalline n-(s-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
US5134225A (en) * | 1989-02-21 | 1992-07-28 | Pfizer Inc. | Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-D-alanine |
EP0617009B1 (en) | 1992-10-15 | 1999-09-08 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Novel amino acid derivative |
US5798387A (en) * | 1992-10-15 | 1998-08-25 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Amino acid derivatives |
US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
US7795210B2 (en) * | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
US7399613B2 (en) * | 2001-10-10 | 2008-07-15 | Neose Technologies, Inc. | Sialic acid nucleotide sugars |
US7696163B2 (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7157277B2 (en) * | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
US8008252B2 (en) * | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
US7173003B2 (en) * | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
MXPA04012496A (es) * | 2002-06-21 | 2005-09-12 | Novo Nordisk Healthcare Ag | Glicoformos del factor vii pegilados. |
CA2519092C (en) * | 2003-03-14 | 2014-08-05 | Neose Technologies, Inc. | Branched water-soluble polymers and their conjugates |
WO2007022512A2 (en) * | 2005-08-19 | 2007-02-22 | Neose Technologies, Inc. | Glycopegylated factor vii and factor viia |
US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
US7691603B2 (en) * | 2003-04-09 | 2010-04-06 | Novo Nordisk A/S | Intracellular formation of peptide conjugates |
PL1615945T3 (pl) | 2003-04-09 | 2012-03-30 | Ratiopharm Gmbh | Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami |
BRPI0410164A (pt) | 2003-05-09 | 2006-05-16 | Neose Technologies Inc | composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US8633157B2 (en) * | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
KR20060120141A (ko) * | 2003-11-24 | 2006-11-24 | 네오스 테크놀로지스, 인크. | 글리코페질화 에리트로포이에틴 |
US20080305992A1 (en) * | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US20060040856A1 (en) * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
US7956032B2 (en) * | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
BRPI0417342A (pt) * | 2003-12-03 | 2007-04-17 | Neose Technologies Inc | fator estimulante de colÈnia de granulócitos glicopeguilado |
US20080318850A1 (en) * | 2003-12-03 | 2008-12-25 | Neose Technologies, Inc. | Glycopegylated Factor Ix |
KR101439880B1 (ko) * | 2004-01-08 | 2014-09-12 | 라티오팜 게엠베하 | 펩티드의 오-결합형 글리코실화 |
EP1771066A2 (en) | 2004-07-13 | 2007-04-11 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1 |
EP1799249A2 (en) * | 2004-09-10 | 2007-06-27 | Neose Technologies, Inc. | Glycopegylated interferon alpha |
WO2006050247A2 (en) * | 2004-10-29 | 2006-05-11 | Neose Technologies, Inc. | Remodeling and glycopegylation of fibroblast growth factor (fgf) |
EP1838332A1 (en) * | 2005-01-06 | 2007-10-03 | Neose Technologies, Inc. | Glycoconjugation using saccharyl fragments |
NZ556436A (en) * | 2005-01-10 | 2010-11-26 | Biogenerix Ag | Glycopegylated granulocyte colony stimulating factor |
WO2006105426A2 (en) * | 2005-03-30 | 2006-10-05 | Neose Technologies, Inc. | Manufacturing process for the production of peptides grown in insect cell lines |
EP2386571B1 (en) * | 2005-04-08 | 2016-06-01 | ratiopharm GmbH | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
WO2006127910A2 (en) * | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Glycopegylated erythropoietin formulations |
JP5216580B2 (ja) * | 2005-05-25 | 2013-06-19 | ノヴォ ノルディスク アー/エス | グリコペグ化第ix因子 |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
US20090048440A1 (en) * | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
ES2516694T3 (es) * | 2006-07-21 | 2014-10-31 | Ratiopharm Gmbh | Glicosilación de péptidos a través de secuencias de glicosilación con unión en O |
WO2008057683A2 (en) * | 2006-10-03 | 2008-05-15 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates |
LT2068907T (lt) * | 2006-10-04 | 2018-01-10 | Novo Nordisk A/S | Glicerolio sujungti pegilinti sacharidai ir glikopeptidai |
WO2008073620A2 (en) * | 2006-11-02 | 2008-06-19 | Neose Technologies, Inc. | Manufacturing process for the production of polypeptides expressed in insect cell-lines |
BRPI0809670A8 (pt) * | 2007-04-03 | 2018-12-18 | Biogenerix Ag | métodos para aumentar a produção de célula tronco, para aumentar o número de granulócitos em um indivíduo, para prevenir, tratar e aliviar a mielossupressão que resulta de uma terapia contra o câncer, para tratar uma condição em um indivíduo, para tratar neutropenia e trombocitopenia em um mamífero, para expandir células tronco hematopoiéticas em cultura, para aumentar a hematopoiese em um indivíduo, para aumentar o número de célulars progenitoras hematopoiéticas em um indivíduo, e para fornecer enxerto estável da medula óssea, e, forma de dosagem oral. |
US20090053167A1 (en) * | 2007-05-14 | 2009-02-26 | Neose Technologies, Inc. | C-, S- and N-glycosylation of peptides |
US20110177029A1 (en) * | 2007-06-04 | 2011-07-21 | Novo Nordisk A/S | O-linked glycosylation using n-acetylglucosaminyl transferases |
CN101778859B (zh) * | 2007-06-12 | 2014-03-26 | 诺和诺德公司 | 改良的用于生产核苷酸糖的方法 |
US8207112B2 (en) * | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
US20100286067A1 (en) * | 2008-01-08 | 2010-11-11 | Biogenerix Ag | Glycoconjugation of polypeptides using oligosaccharyltransferases |
CN103497246B (zh) | 2008-02-27 | 2016-08-10 | 诺沃—诺迪斯克有限公司 | 缀合的因子viii分子 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4322341A (en) * | 1980-05-13 | 1982-03-30 | Fujisawa Pharmaceutical Co | Peptide, process for preparation thereof and use thereof |
DK156252C (da) * | 1979-07-31 | 1989-12-18 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf |
DE3070278D1 (en) * | 1979-10-11 | 1985-04-18 | Fujisawa Pharmaceutical Co | Peptides, processes for their preparation and pharmaceutical compositions containing them |
GR81332B (es) * | 1980-12-01 | 1984-12-11 | Fujisawa Pharmaceutical Co | |
US4493794A (en) * | 1980-12-31 | 1985-01-15 | Fujisawa Pharmaceutical Co., Ltd. | Peptide, process for preparation thereof and use thereof |
-
1984
- 1984-03-30 US US06/595,169 patent/US4565653A/en not_active Expired - Fee Related
-
1985
- 1985-03-26 EP EP85302065A patent/EP0157572A3/en not_active Withdrawn
- 1985-03-26 PH PH32046A patent/PH21303A/en unknown
- 1985-03-27 ES ES541620A patent/ES8605821A1/es not_active Expired
- 1985-03-28 EG EG201/85A patent/EG17928A/xx active
- 1985-03-28 GR GR850783A patent/GR850783B/el unknown
- 1985-03-28 ZA ZA852335A patent/ZA852335B/xx unknown
- 1985-03-28 PT PT80181A patent/PT80181B/pt not_active IP Right Cessation
- 1985-03-28 DD DD85274551A patent/DD239406A5/de not_active IP Right Cessation
- 1985-03-28 CA CA000477796A patent/CA1270098A/en not_active Expired - Fee Related
- 1985-03-29 PL PL25265985A patent/PL252659A1/xx unknown
- 1985-03-29 HU HU851217A patent/HU198086B/hu unknown
- 1985-03-29 NO NO851278A patent/NO851278L/no unknown
- 1985-03-29 DK DK142485A patent/DK142485A/da not_active Application Discontinuation
- 1985-03-29 FI FI851271A patent/FI851271L/fi not_active Application Discontinuation
- 1985-03-29 KR KR1019850002106A patent/KR870000372B1/ko not_active IP Right Cessation
- 1985-03-29 NZ NZ211634A patent/NZ211634A/xx unknown
- 1985-03-29 AU AU40523/85A patent/AU552919B2/en not_active Ceased
- 1985-03-29 IL IL74758A patent/IL74758A/xx unknown
- 1985-03-29 JP JP60066380A patent/JPS60224699A/ja active Pending
-
1986
- 1986-04-22 AU AU56476/86A patent/AU566460B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
HUT37443A (en) | 1985-12-28 |
PT80181A (en) | 1985-04-01 |
KR850006939A (ko) | 1985-10-25 |
IL74758A0 (en) | 1985-06-30 |
AU5647686A (en) | 1986-09-04 |
NO851278L (no) | 1985-10-01 |
EP0157572A3 (en) | 1987-01-07 |
HU198086B (en) | 1989-07-28 |
AU566460B2 (en) | 1987-10-22 |
ZA852335B (en) | 1986-11-26 |
US4565653A (en) | 1986-01-21 |
DK142485D0 (da) | 1985-03-29 |
JPS60224699A (ja) | 1985-11-09 |
AU552919B2 (en) | 1986-06-26 |
DK142485A (da) | 1985-10-01 |
PT80181B (en) | 1987-03-20 |
NZ211634A (en) | 1988-10-28 |
PL252659A1 (en) | 1985-11-19 |
KR870000372B1 (ko) | 1987-03-06 |
FI851271L (fi) | 1985-10-01 |
DD239406A5 (de) | 1986-09-24 |
PH21303A (en) | 1987-09-28 |
CA1270098A (en) | 1990-06-05 |
FI851271A0 (fi) | 1985-03-29 |
EG17928A (en) | 1991-08-30 |
ES8605821A1 (es) | 1986-04-01 |
GR850783B (es) | 1985-11-25 |
EP0157572A2 (en) | 1985-10-09 |
IL74758A (en) | 1988-06-30 |
AU4052385A (en) | 1985-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES541620A0 (es) | Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes | |
ES547840A0 (es) | Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas | |
ES551249A0 (es) | Un procedimiento para la preparacion de peptidilaminodioles. | |
ES557743A0 (es) | Un procedimiento para la preparacion de nuevas piranopiridinas | |
ES546800A0 (es) | Un procedimiento para la preparacion de surfactantes de fos-fato | |
ES540366A0 (es) | Un procedimiento para la preparacion de un compuesto | |
ES556738A0 (es) | Un procedimiento para la preparacion de nuevos piridazinaminas. | |
ES554983A0 (es) | Un procedimiento para la preparacion de silileteres. | |
ES557126A0 (es) | Un procedimiento para la preparacion de triazolobenzodiazepinas | |
ES557413A0 (es) | Un procedimiento para la preparacion de un polialquenoilisocianato | |
ES540200A0 (es) | Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos | |
ES557772A0 (es) | Un procedimiento para la preparacion de epipodofilotoxina | |
ES545298A0 (es) | Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas | |
ES553602A0 (es) | Un procedimiento para la preparacion de nuevas quinazolindionas | |
ES557427A0 (es) | Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas | |
ES553703A0 (es) | Un procedimiento para la preparacion de vesiculas de fosfoliptidos. | |
ES541373A0 (es) | Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida | |
ES551508A0 (es) | Un procedimiento para la preparacion de nuevas sulfonilureas | |
ES555298A0 (es) | Un procedimiento para la preparacion de nuevos esteroides 11-b-sustituidos. | |
ES542517A0 (es) | Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas | |
ES555670A0 (es) | Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas. | |
ES551129A0 (es) | Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil- o n-pirazinil-propilaminas | |
ES544397A0 (es) | Un procedimiento para la preparacion de un compuesto | |
ES552986A0 (es) | Un procedimiento para la preparacion de piridazinilimidazolidinonas | |
ES556807A0 (es) | Un procedimiento para la preparacion de nuevos 11-metileno-esteroides. |